APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automated Biobanking Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Automated Biobanking Solution Market Analysis and Forecast 2026-2032

16 April 2026256 pages

Choose your research edition.

Industry ResearchAutomated Biobanking Solution Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Automated Biobanking Solution Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Automated Biobanking Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automated Biobanking Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Automated Biobanking Solution Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global Automated Biobanking Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Automated Biobanking Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Automated Biobanking Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Automated Biobanking Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Automated Biobanking Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Automated Biobanking Solution include Thermo Fisher Scientific, Air Liquide, Brooks Automation, SPT Labtech, Modul-Bio, Azenta, LabVantage, OMNI Life Science and Calibre Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Automated Biobanking Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Automated Biobanking Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Automated Biobanking Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Automated Biobanking Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Automated Biobanking Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Automated Biobanking Solution revenue, projected growth trends, production technology, application and end-user industry.

Automated Biobanking Solution Segment by Company

Thermo Fisher Scientific

Air Liquide

Brooks Automation

SPT Labtech

Modul-Bio

Azenta

LabVantage

OMNI Life Science

Calibre Scientific

IQVIA

XiltriX

Esco Lifesciences Group

Hangzhou Baocheng Biotechnology

Shanghai Origincell Biological Cryo Equipment

Anhui Zhongke Meiling Cryogenics

Shanghai H-VISIONS Technology

Qingdao Haier Biomedical

Qingdao AUCMA Biomedical

Qingdao Dashoo

Qingdao Hisense Medical

Automated Biobanking Solution Segment by Type

Sample Preparation Devices

Cryobiology Storage System

Cryobiology Storage Consumables

Environmental Monitoring System

Laboratory Information Management Systems (LIMS)

Automated Biobanking Solution Segment by Application

Universities

Hospitals

Clinical Research Laboratories

Others

Automated Biobanking Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated Biobanking Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automated Biobanking Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated Biobanking Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Automated Biobanking Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Automated Biobanking Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Automated Biobanking Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Automated Biobanking Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sample Preparation Devices Major Player Table 3. Cryobiology Storage System Major Player Table 4. Cryobiology Storage Consumables Major Player Table 5. Environmental Monitoring System Major Player Table 6. Laboratory Information Management Systems (LIMS) Major Player Table 7. Global Automated Biobanking Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Universities Major Player Table 9. Hospitals Major Player Table 10. Clinical Research Laboratories Major Player Table 11. Others Major Player Table 12. Automated Biobanking Solution Industry Trends Table 13. Automated Biobanking Solution Industry Drivers Table 14. Automated Biobanking Solution Industry Opportunities and Challenges Table 15. Automated Biobanking Solution Industry Restraints Table 16. Global Automated Biobanking Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Automated Biobanking Solution Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Automated Biobanking Solution Market Share by Region (2021-2026) Table 19. Global Automated Biobanking Solution Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Automated Biobanking Solution Market Share by Region (2027-2032) Table 21. Global Automated Biobanking Solution Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Automated Biobanking Solution Revenue Market Share by Players (2021-2026) Table 23. Global Automated Biobanking Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Automated Biobanking Solution Key Players Headquarters & Area Served Table 25. Global Automated Biobanking Solution Players, Product Type & Application Table 26. Global Automated Biobanking Solution Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Automated Biobanking Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Automated Biobanking Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Automated Biobanking Solution Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Automated Biobanking Solution Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Automated Biobanking Solution Revenue Market Share by Type (2021-2026) Table 33. Global Automated Biobanking Solution Revenue Market Share by Type (2027-2032) Table 34. Global Automated Biobanking Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Automated Biobanking Solution Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Automated Biobanking Solution Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Automated Biobanking Solution Revenue Market Share by Application (2021-2026) Table 38. Global Automated Biobanking Solution Revenue Market Share by Application (2027-2032) Table 39. Thermo Fisher Scientific Company Information Table 40. Thermo Fisher Scientific Business Overview Table 41. Thermo Fisher Scientific Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Thermo Fisher Scientific Automated Biobanking Solution Product Portfolio Table 43. Thermo Fisher Scientific Recent Development Table 44. Air Liquide Company Information Table 45. Air Liquide Business Overview Table 46. Air Liquide Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Air Liquide Automated Biobanking Solution Product Portfolio Table 48. Air Liquide Recent Development Table 49. Brooks Automation Company Information Table 50. Brooks Automation Business Overview Table 51. Brooks Automation Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Brooks Automation Automated Biobanking Solution Product Portfolio Table 53. Brooks Automation Recent Development Table 54. SPT Labtech Company Information Table 55. SPT Labtech Business Overview Table 56. SPT Labtech Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SPT Labtech Automated Biobanking Solution Product Portfolio Table 58. SPT Labtech Recent Development Table 59. Modul-Bio Company Information Table 60. Modul-Bio Business Overview Table 61. Modul-Bio Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Modul-Bio Automated Biobanking Solution Product Portfolio Table 63. Modul-Bio Recent Development Table 64. Azenta Company Information Table 65. Azenta Business Overview Table 66. Azenta Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Azenta Automated Biobanking Solution Product Portfolio Table 68. Azenta Recent Development Table 69. LabVantage Company Information Table 70. LabVantage Business Overview Table 71. LabVantage Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. LabVantage Automated Biobanking Solution Product Portfolio Table 73. LabVantage Recent Development Table 74. OMNI Life Science Company Information Table 75. OMNI Life Science Business Overview Table 76. OMNI Life Science Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. OMNI Life Science Automated Biobanking Solution Product Portfolio Table 78. OMNI Life Science Recent Development Table 79. Calibre Scientific Company Information Table 80. Calibre Scientific Business Overview Table 81. Calibre Scientific Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Calibre Scientific Automated Biobanking Solution Product Portfolio Table 83. Calibre Scientific Recent Development Table 84. IQVIA Company Information Table 85. IQVIA Business Overview Table 86. IQVIA Automated Biobanking Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. IQVIA Automated Biobanking Solution Product Portfolio Table 88. IQVIA Recent Development Table 89. XiltriX Company Information Table 90. XiltriX Business Overview Table 91. XiltriX Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. XiltriX Automated Biobanking Solution Product Portfolio Table 93. XiltriX Recent Development Table 94. Esco Lifesciences Group Company Information Table 95. Esco Lifesciences Group Business Overview Table 96. Esco Lifesciences Group Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Esco Lifesciences Group Automated Biobanking Solution Product Portfolio Table 98. Esco Lifesciences Group Recent Development Table 99. Hangzhou Baocheng Biotechnology Company Information Table 100. Hangzhou Baocheng Biotechnology Business Overview Table 101. Hangzhou Baocheng Biotechnology Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Hangzhou Baocheng Biotechnology Automated Biobanking Solution Product Portfolio Table 103. Hangzhou Baocheng Biotechnology Recent Development Table 104. Shanghai Origincell Biological Cryo Equipment Company Information Table 105. Shanghai Origincell Biological Cryo Equipment Business Overview Table 106. Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Product Portfolio Table 108. Shanghai Origincell Biological Cryo Equipment Recent Development Table 109. Anhui Zhongke Meiling Cryogenics Company Information Table 110. Anhui Zhongke Meiling Cryogenics Business Overview Table 111. Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Product Portfolio Table 113. Anhui Zhongke Meiling Cryogenics Recent Development Table 114. Shanghai H-VISIONS Technology Company Information Table 115. Shanghai H-VISIONS Technology Business Overview Table 116. Shanghai H-VISIONS Technology Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Shanghai H-VISIONS Technology Automated Biobanking Solution Product Portfolio Table 118. Shanghai H-VISIONS Technology Recent Development Table 119. Qingdao Haier Biomedical Company Information Table 120. Qingdao Haier Biomedical Business Overview Table 121. Qingdao Haier Biomedical Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Qingdao Haier Biomedical Automated Biobanking Solution Product Portfolio Table 123. Qingdao Haier Biomedical Recent Development Table 124. Qingdao AUCMA Biomedical Company Information Table 125. Qingdao AUCMA Biomedical Business Overview Table 126. Qingdao AUCMA Biomedical Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Qingdao AUCMA Biomedical Automated Biobanking Solution Product Portfolio Table 128. Qingdao AUCMA Biomedical Recent Development Table 129. Qingdao Dashoo Company Information Table 130. Qingdao Dashoo Business Overview Table 131. Qingdao Dashoo Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Qingdao Dashoo Automated Biobanking Solution Product Portfolio Table 133. Qingdao Dashoo Recent Development Table 134. Qingdao Hisense Medical Company Information Table 135. Qingdao Hisense Medical Business Overview Table 136. Qingdao Hisense Medical Automated Biobanking Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Qingdao Hisense Medical Automated Biobanking Solution Product Portfolio Table 138. Qingdao Hisense Medical Recent Development Table 139. North America Automated Biobanking Solution Revenue by Type (2021-2026) & (US$ Million) Table 140. North America Automated Biobanking Solution Revenue by Type (2027-2032) & (US$ Million) Table 141. North America Automated Biobanking Solution Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Automated Biobanking Solution Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Automated Biobanking Solution Revenue by Country (2021-2026) & (US$ Million) Table 145. North America Automated Biobanking Solution Revenue by Country (US$ Million) & (2027-2032) Table 146. Europe Automated Biobanking Solution Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Automated Biobanking Solution Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Automated Biobanking Solution Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe Automated Biobanking Solution Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Automated Biobanking Solution Revenue by Country (2021-2026) & (US$ Million) Table 152. Europe Automated Biobanking Solution Revenue by Country (US$ Million) & (2027-2032) Table 153. China Automated Biobanking Solution Revenue by Type (2021-2026) & (US$ Million) Table 154. China Automated Biobanking Solution Revenue by Type (2027-2032) & (US$ Million) Table 155. China Automated Biobanking Solution Revenue by Application (2021-2026) & (US$ Million) Table 156. China Automated Biobanking Solution Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Automated Biobanking Solution Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Automated Biobanking Solution Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Automated Biobanking Solution Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Automated Biobanking Solution Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Automated Biobanking Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Automated Biobanking Solution Revenue by Region (US$ Million) & (2021-2026) Table 163. Asia Automated Biobanking Solution Revenue by Region (US$ Million) & (2027-2032) Table 164. SAMEA Automated Biobanking Solution Revenue by Type (2021-2026) & (US$ Million) Table 165. SAMEA Automated Biobanking Solution Revenue by Type (2027-2032) & (US$ Million) Table 166. SAMEA Automated Biobanking Solution Revenue by Application (2021-2026) & (US$ Million) Table 167. SAMEA Automated Biobanking Solution Revenue by Application (2027-2032) & (US$ Million) Table 168. SAMEA Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. SAMEA Automated Biobanking Solution Revenue by Country (2021-2026) & (US$ Million) Table 170. SAMEA Automated Biobanking Solution Revenue by Country (US$ Million) & (2027-2032) Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Automated Biobanking Solution Image Figure 2. Global Automated Biobanking Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automated Biobanking Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sample Preparation Devices Image Figure 5. Cryobiology Storage System Image Figure 6. Cryobiology Storage Consumables Image Figure 7. Environmental Monitoring System Image Figure 8. Laboratory Information Management Systems (LIMS) Image Figure 9. Global Automated Biobanking Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Automated Biobanking Solution Market Size Share 2021 VS 2025 VS 2032 Figure 11. Universities Image Figure 12. Hospitals Image Figure 13. Clinical Research Laboratories Image Figure 14. Others Image Figure 15. Global Automated Biobanking Solution Market Size (US$ Million) & (2021-2032) Figure 16. Global Automated Biobanking Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Automated Biobanking Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Automated Biobanking Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Automated Biobanking Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Automated Biobanking Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Automated Biobanking Solution Revenue Market Share by Type (2021-2032) Figure 23. Global Automated Biobanking Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Automated Biobanking Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Automated Biobanking Solution Revenue Market Share by Application (2021-2032) Figure 26. North America Automated Biobanking Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Automated Biobanking Solution Revenue Share by Type (2021-2032) Figure 28. North America Automated Biobanking Solution Revenue Share by Application (2021-2032) Figure 29. North America Automated Biobanking Solution Revenue Share by Country (2021-2032) Figure 30. United States Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Automated Biobanking Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Automated Biobanking Solution Revenue Share by Type (2021-2032) Figure 35. Europe Automated Biobanking Solution Revenue Share by Application (2021-2032) Figure 36. Europe Automated Biobanking Solution Revenue Share by Country (2021-2032) Figure 37. Germany Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Automated Biobanking Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Automated Biobanking Solution Revenue Share by Type (2021-2032) Figure 47. China Automated Biobanking Solution Revenue Share by Application (2021-2032) Figure 48. Asia Automated Biobanking Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Automated Biobanking Solution Revenue Share by Type (2021-2032) Figure 50. Asia Automated Biobanking Solution Revenue Share by Application (2021-2032) Figure 51. Asia Automated Biobanking Solution Revenue Share by Region (2021-2032) Figure 52. Japan Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Automated Biobanking Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Automated Biobanking Solution Revenue Share by Type (2021-2032) Figure 60. SAMEA Automated Biobanking Solution Revenue Share by Application (2021-2032) Figure 61. SAMEA Automated Biobanking Solution Revenue Share by Country (2021-2032) Figure 62. Brazil Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Automated Biobanking Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Sample Preparation Devices
  • Cryobiology Storage System
  • Cryobiology Storage Consumables
  • Environmental Monitoring System
  • Laboratory Information Management Systems (LIMS)
Applications
  • Universities
  • Hospitals
  • Clinical Research Laboratories
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Air Liquide
  • Brooks Automation
  • SPT Labtech
  • Modul-Bio
  • Azenta
  • LabVantage
  • OMNI Life Science
  • Calibre Scientific
  • IQVIA
  • XiltriX
  • Esco Lifesciences Group
  • Hangzhou Baocheng Biotechnology
  • Shanghai Origincell Biological Cryo Equipment
  • Anhui Zhongke Meiling Cryogenics
  • Shanghai H-VISIONS Technology
  • Qingdao Haier Biomedical
  • Qingdao AUCMA Biomedical
  • Qingdao Dashoo
  • Qingdao Hisense Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Automated Biobanking Solution Market by Type
  3. 1.2.1 Global Automated Biobanking Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sample Preparation Devices
  5. 1.2.3 Cryobiology Storage System
  6. 1.2.4 Cryobiology Storage Consumables
  7. 1.2.5 Environmental Monitoring System
  8. 1.2.6 Laboratory Information Management Systems (LIMS)
  9. 1.3 Automated Biobanking Solution Market by Application
  10. 1.3.1 Global Automated Biobanking Solution Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Universities
  12. 1.3.3 Hospitals
  13. 1.3.4 Clinical Research Laboratories
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Automated Biobanking Solution Market Dynamics
  1. 2.1 Automated Biobanking Solution Industry Trends
  2. 2.2 Automated Biobanking Solution Industry Drivers
  3. 2.3 Automated Biobanking Solution Industry Opportunities and Challenges
  4. 2.4 Automated Biobanking Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Automated Biobanking Solution Market Perspective (2021-2032)
  2. 3.2 Global Automated Biobanking Solution Growth Trends by Region
  3. 3.2.1 Global Automated Biobanking Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Automated Biobanking Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Automated Biobanking Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Automated Biobanking Solution Revenue by Players
  2. 4.1.1 Global Automated Biobanking Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Automated Biobanking Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Automated Biobanking Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Automated Biobanking Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Automated Biobanking Solution Key Players Headquarters & Area Served
  7. 4.4 Global Automated Biobanking Solution Players, Product Type & Application
  8. 4.5 Global Automated Biobanking Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Automated Biobanking Solution Market CR5 and HHI
  11. 4.6.3 2025 Automated Biobanking Solution Tier 1, Tier 2, and Tier 3
5 Automated Biobanking Solution Market Size by Type
  1. 5.1 Global Automated Biobanking Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Automated Biobanking Solution Revenue by Type (2021-2032)
  3. 5.3 Global Automated Biobanking Solution Revenue Market Share by Type (2021-2032)
6 Automated Biobanking Solution Market Size by Application
  1. 6.1 Global Automated Biobanking Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Automated Biobanking Solution Revenue by Application (2021-2032)
  3. 6.3 Global Automated Biobanking Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Automated Biobanking Solution Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Air Liquide
  8. 7.2.1 Air Liquide Company Information
  9. 7.2.2 Air Liquide Business Overview
  10. 7.2.3 Air Liquide Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Air Liquide Automated Biobanking Solution Product Portfolio
  12. 7.2.5 Air Liquide Recent Developments
  13. 7.3 Brooks Automation
  14. 7.3.1 Brooks Automation Company Information
  15. 7.3.2 Brooks Automation Business Overview
  16. 7.3.3 Brooks Automation Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Brooks Automation Automated Biobanking Solution Product Portfolio
  18. 7.3.5 Brooks Automation Recent Developments
  19. 7.4 SPT Labtech
  20. 7.4.1 SPT Labtech Company Information
  21. 7.4.2 SPT Labtech Business Overview
  22. 7.4.3 SPT Labtech Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SPT Labtech Automated Biobanking Solution Product Portfolio
  24. 7.4.5 SPT Labtech Recent Developments
  25. 7.5 Modul-Bio
  26. 7.5.1 Modul-Bio Company Information
  27. 7.5.2 Modul-Bio Business Overview
  28. 7.5.3 Modul-Bio Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Modul-Bio Automated Biobanking Solution Product Portfolio
  30. 7.5.5 Modul-Bio Recent Developments
  31. 7.6 Azenta
  32. 7.6.1 Azenta Company Information
  33. 7.6.2 Azenta Business Overview
  34. 7.6.3 Azenta Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Azenta Automated Biobanking Solution Product Portfolio
  36. 7.6.5 Azenta Recent Developments
  37. 7.7 LabVantage
  38. 7.7.1 LabVantage Company Information
  39. 7.7.2 LabVantage Business Overview
  40. 7.7.3 LabVantage Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 LabVantage Automated Biobanking Solution Product Portfolio
  42. 7.7.5 LabVantage Recent Developments
  43. 7.8 OMNI Life Science
  44. 7.8.1 OMNI Life Science Company Information
  45. 7.8.2 OMNI Life Science Business Overview
  46. 7.8.3 OMNI Life Science Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 OMNI Life Science Automated Biobanking Solution Product Portfolio
  48. 7.8.5 OMNI Life Science Recent Developments
  49. 7.9 Calibre Scientific
  50. 7.9.1 Calibre Scientific Company Information
  51. 7.9.2 Calibre Scientific Business Overview
  52. 7.9.3 Calibre Scientific Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Calibre Scientific Automated Biobanking Solution Product Portfolio
  54. 7.9.5 Calibre Scientific Recent Developments
  55. 7.10 IQVIA
  56. 7.10.1 IQVIA Company Information
  57. 7.10.2 IQVIA Business Overview
  58. 7.10.3 IQVIA Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IQVIA Automated Biobanking Solution Product Portfolio
  60. 7.10.5 IQVIA Recent Developments
  61. 7.11 XiltriX
  62. 7.11.1 XiltriX Company Information
  63. 7.11.2 XiltriX Business Overview
  64. 7.11.3 XiltriX Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 XiltriX Automated Biobanking Solution Product Portfolio
  66. 7.11.5 XiltriX Recent Developments
  67. 7.12 Esco Lifesciences Group
  68. 7.12.1 Esco Lifesciences Group Company Information
  69. 7.12.2 Esco Lifesciences Group Business Overview
  70. 7.12.3 Esco Lifesciences Group Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Esco Lifesciences Group Automated Biobanking Solution Product Portfolio
  72. 7.12.5 Esco Lifesciences Group Recent Developments
  73. 7.13 Hangzhou Baocheng Biotechnology
  74. 7.13.1 Hangzhou Baocheng Biotechnology Company Information
  75. 7.13.2 Hangzhou Baocheng Biotechnology Business Overview
  76. 7.13.3 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Product Portfolio
  78. 7.13.5 Hangzhou Baocheng Biotechnology Recent Developments
  79. 7.14 Shanghai Origincell Biological Cryo Equipment
  80. 7.14.1 Shanghai Origincell Biological Cryo Equipment Company Information
  81. 7.14.2 Shanghai Origincell Biological Cryo Equipment Business Overview
  82. 7.14.3 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Product Portfolio
  84. 7.14.5 Shanghai Origincell Biological Cryo Equipment Recent Developments
  85. 7.15 Anhui Zhongke Meiling Cryogenics
  86. 7.15.1 Anhui Zhongke Meiling Cryogenics Company Information
  87. 7.15.2 Anhui Zhongke Meiling Cryogenics Business Overview
  88. 7.15.3 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Product Portfolio
  90. 7.15.5 Anhui Zhongke Meiling Cryogenics Recent Developments
  91. 7.16 Shanghai H-VISIONS Technology
  92. 7.16.1 Shanghai H-VISIONS Technology Company Information
  93. 7.16.2 Shanghai H-VISIONS Technology Business Overview
  94. 7.16.3 Shanghai H-VISIONS Technology Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Shanghai H-VISIONS Technology Automated Biobanking Solution Product Portfolio
  96. 7.16.5 Shanghai H-VISIONS Technology Recent Developments
  97. 7.17 Qingdao Haier Biomedical
  98. 7.17.1 Qingdao Haier Biomedical Company Information
  99. 7.17.2 Qingdao Haier Biomedical Business Overview
  100. 7.17.3 Qingdao Haier Biomedical Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Qingdao Haier Biomedical Automated Biobanking Solution Product Portfolio
  102. 7.17.5 Qingdao Haier Biomedical Recent Developments
  103. 7.18 Qingdao AUCMA Biomedical
  104. 7.18.1 Qingdao AUCMA Biomedical Company Information
  105. 7.18.2 Qingdao AUCMA Biomedical Business Overview
  106. 7.18.3 Qingdao AUCMA Biomedical Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Qingdao AUCMA Biomedical Automated Biobanking Solution Product Portfolio
  108. 7.18.5 Qingdao AUCMA Biomedical Recent Developments
  109. 7.19 Qingdao Dashoo
  110. 7.19.1 Qingdao Dashoo Company Information
  111. 7.19.2 Qingdao Dashoo Business Overview
  112. 7.19.3 Qingdao Dashoo Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Qingdao Dashoo Automated Biobanking Solution Product Portfolio
  114. 7.19.5 Qingdao Dashoo Recent Developments
  115. 7.20 Qingdao Hisense Medical
  116. 7.20.1 Qingdao Hisense Medical Company Information
  117. 7.20.2 Qingdao Hisense Medical Business Overview
  118. 7.20.3 Qingdao Hisense Medical Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Qingdao Hisense Medical Automated Biobanking Solution Product Portfolio
  120. 7.20.5 Qingdao Hisense Medical Recent Developments
8 North America
  1. 8.1 North America Automated Biobanking Solution Revenue (2021-2032)
  2. 8.2 North America Automated Biobanking Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Automated Biobanking Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Automated Biobanking Solution Revenue by Type (2027-2032)
  5. 8.3 North America Automated Biobanking Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Automated Biobanking Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Automated Biobanking Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Automated Biobanking Solution Revenue by Application (2027-2032)
  9. 8.5 North America Automated Biobanking Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Automated Biobanking Solution Revenue by Country
  11. 8.6.1 North America Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Automated Biobanking Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Automated Biobanking Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Automated Biobanking Solution Revenue (2021-2032)
  2. 9.2 Europe Automated Biobanking Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Automated Biobanking Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Automated Biobanking Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Automated Biobanking Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Automated Biobanking Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Automated Biobanking Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Automated Biobanking Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Automated Biobanking Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Automated Biobanking Solution Revenue by Country
  11. 9.6.1 Europe Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Automated Biobanking Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Automated Biobanking Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Automated Biobanking Solution Revenue (2021-2032)
  2. 10.2 China Automated Biobanking Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Automated Biobanking Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Automated Biobanking Solution Revenue by Type (2027-2032)
  5. 10.3 China Automated Biobanking Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Automated Biobanking Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Automated Biobanking Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Automated Biobanking Solution Revenue by Application (2027-2032)
  9. 10.5 China Automated Biobanking Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Automated Biobanking Solution Revenue (2021-2032)
  2. 11.2 Asia Automated Biobanking Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Automated Biobanking Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Automated Biobanking Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Automated Biobanking Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Automated Biobanking Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Automated Biobanking Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Automated Biobanking Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Automated Biobanking Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Automated Biobanking Solution Revenue by Country
  11. 11.6.1 Asia Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Automated Biobanking Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Automated Biobanking Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Automated Biobanking Solution Revenue (2021-2032)
  2. 12.2 SAMEA Automated Biobanking Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Automated Biobanking Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Automated Biobanking Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Automated Biobanking Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Automated Biobanking Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Automated Biobanking Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Automated Biobanking Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Automated Biobanking Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Automated Biobanking Solution Revenue by Country
  11. 12.6.1 SAMEA Automated Biobanking Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Automated Biobanking Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Automated Biobanking Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst